Jinling Pharmaceutical Co.,Ltd.’s Net Profit Dropped 27.4% in First Half of 2022

Jinling Pharmaceutical Co.,Ltd. (金陵药业股份有限公司) (000919.SZ) reported a net profit of 68.2 million yuan in the first half of 2022, down 27.4% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, down 4.9% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 887 million yuan in total liabilities, with a liability-to-asset ratio of 19.7%.